Company: QXO-PB
Filing Date: 2025-04-16
Form Type: 424B5
Source: 0001140361-25-014221
Chunk: 15

Company: QXO, Inc.
Filing Date: 2025-04-16
Form: 424B5
Chunk 15
---
, we entered into commitment letters with Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc., Citigroup Global Markets Inc., Crédit Agricole Corporate and Investment Bank, Wells Fargo Bank, National Association, Wells Fargo Securities, LLC and Mizuho Bank, Ltd. (collectively, the “Commitment Parties”), pursuant to which the Commitment Parties committed to provide up to $6.5 billion of funded indebtedness (the “Committed Financing”) in the form of term loans and bridge loans to finance the Acquisition and a $1.75 billion asset-based revolving credit facility, subject to the terms and conditions set forth therein. If we do not generate sufficient net proceeds from this offering of Common Stock and the expected offering of Notes, we may be required to utilize a greater portion of the Committed Financing, including drawing on the bridge loans.

There can be no assurance that the Debt Financings will be completed on the terms described in this prospectus supplement, or at all. The completion of this offering is not contingent on the completion of the Debt Financings or the Acquisition. Accordingly, even if the Acquisition or any or all of the Debt Financings do not occur, the shares of Common Stock sold in this offering will remain outstanding, and investors will not have any rights to require us to repurchase, redeem or repay any shares of Common Stock sold in this offering. If the Acquisition is not consummated, we intend to use the net proceeds from this offering for general corporate purposes. We do not expect any debt under the Credit Facilities will be incurred or the Notes will be issued if the Acquisition is not consummated. This prospectus supplement is not an offer to sell or a solicitation of offer to purchase with respect to the potential offering of Notes.

#### Private Placement
On March 17, 2025, QXO entered into purchase agreements (together, the “Purchase Agreements”) with certain institutional investors named therein, pursuant to which we agreed to issue and sell to such investors in a private placement (the “Private Placement”) approximately 67.5 million shares (the “Shares”) of Common Stock, at a purchase price of $12.30 per share. The aggregate gross proceeds from the Private Placement is expected to be approximately $830 million, before deducting agent fees and offering expenses. The closing of the

<div align='center'>S-6</div>

#### TABLE OF CONTENTS
Private Placement is contingent upon the concurrent consummation of the Acquisition. We expect